Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • tadalafil cas 171596-29-5

Dec . 20, 2024 13:19 Back to list

tadalafil cas 171596-29-5



Tadalafil Understanding Its Mechanism and Therapeutic Applications


Tadalafil, known by its chemical name and CAS number 171596-29-5, is a well-established medication primarily used for treating erectile dysfunction (ED) and the symptoms associated with benign prostatic hyperplasia (BPH). Since its introduction, tadalafil has gained popularity due to its efficacy, long duration of action, and favorable side effect profile.


Mechanism of Action


Tadalafil belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors. The primary action of tadalafil involves the inhibition of the PDE5 enzyme, which is primarily located in the smooth muscle cells of the penis. When sexual stimulation occurs, nitric oxide is released into the corpus cavernosum, leading to an increase in cyclic guanosine monophosphate (cGMP). cGMP causes relaxation of the smooth muscle and dilation of the blood vessels, resulting in increased blood flow into the penis and ultimately facilitating an erection.


In normal physiological conditions, PDE5 breaks down cGMP, leading to a decrease in blood flow and the loss of an erection. By inhibiting the action of PDE5, tadalafil effectively prolongs the effects of cGMP, allowing for improved erectile response during sexual stimulation. This mechanism is the reason why tadalafil is often touted for its ability to provide a firmer and longer-lasting erection compared to other ED treatments.


Therapeutic Uses

Beyond its primary indication for ED, tadalafil has also been approved for the treatment of pulmonary arterial hypertension (PAH) under the brand name Adcirca. In PAH, tadalafil works by relaxing the blood vessels in the lungs, which reduces pulmonary blood pressure and increases exercise capacity in patients. The dual application of tadalafil, addressing both sexual health and pulmonary conditions, demonstrates its versatility and broad therapeutic profile.


tadalafil cas 171596-29-5

tadalafil cas 171596-29-5

In addition to these indications, tadalafil is being investigated for other potential uses, including the treatment of lower urinary tract symptoms related to BPH. BPH can cause urinary symptoms such as increased frequency, urgency, and difficulty in initiating urination. By relaxing prostate and bladder smooth muscle, tadalafil can alleviate these symptoms, improving the quality of life for many patients.


Dosage and Administration


Tadalafil can be taken in two different ways as needed or as a daily medication. For patients seeking treatment for ED, it is commonly prescribed in a dose of 10 mg or 20 mg taken prior to anticipated sexual activity. For those with a consistent need for treatment, a daily lower dose of 2.5 mg or 5 mg may be recommended. The flexibility in dosing allows for personalized treatment plans based on individual lifestyle and preferences.


Safety and Side Effects


Tadalafil is generally well-tolerated, but it can produce side effects in some individuals. Common side effects may include headaches, flushing, nasal congestion, indigestion, and muscle aches. Serious side effects are rare but can include priapism (a prolonged and painful erection), sudden loss of vision, or hearing changes. Patients are advised to consult their healthcare provider before starting tadalafil, especially those with cardiovascular conditions, and to discuss any potential drug interactions.


Conclusion


In summary, tadalafil (CAS 171596-29-5) is a versatile drug with significant benefits for men dealing with erectile dysfunction and individuals suffering from pulmonary arterial hypertension. Its ability to enhance the quality of life through improved sexual health and the management of pulmonary conditions establishes tadalafil as a valuable asset in modern medicine. As ongoing research continues to explore its full spectrum of benefits, tadalafil remains a prominent choice in therapeutic options for millions around the world.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
haHausa
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu haHausa